Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2026-04-15 @ 10:11 AM
Study NCT ID:
NCT01575561
Status:
COMPLETED
Last Update Posted:
2016-08-22
First Post:
2012-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1050308
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None